CHRONIC HEPATITIS B VIRUS INFECTION
Clinical trials for CHRONIC HEPATITIS B VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to clear hepatitis b in HIV patients
Disease control OngoingThis study tests a new drug called bepirovirsen in 153 people who have both HIV and chronic hepatitis B and are already on HIV treatment. The goal is to see if bepirovirsen can clear the hepatitis B virus from the body better than a placebo. Participants will continue their regul…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New drug combo shows promise for tough liver cancer
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in people with advanced liver cancer who also have chronic hepatitis B. The goal is to see if the treatment can shrink or control the cancer. Participants receive the drugs by IV and are monitored for side…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New combo aims to clear hepatitis b virus
Disease control OngoingThis phase 2 study tests whether adding a new drug called BRII-835 to standard pegylated interferon alpha can help people with chronic hepatitis B lose a key virus marker (HBsAg) from their blood. About 86 adults aged 18-60 who have been on antiviral therapy for at least 6 months…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC